These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1749398)

  • 1. Modification of responses of Candida albicans to cisplatin by membrane damaging antimycotic agents.
    Sarachek A; Henderson LA
    Mycoses; 1991; 34(3-4):177-82. PubMed ID: 1749398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the genotoxic spectrum of cisplatin for Candida albicans.
    Sarachek A; Henderson L; Wilkens WE
    Microbios; 1992; 72(292-293):183-201. PubMed ID: 1488020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness, in vitro, of miconazole and ketoconazole combined with tissue conditioners in inhibiting the growth of Candida albicans.
    Quinn DM
    J Oral Rehabil; 1985 Mar; 12(2):177-82. PubMed ID: 3886866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.
    Beggs WH
    Antimicrob Agents Chemother; 1984 Mar; 25(3):316-8. PubMed ID: 6326664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic resistance to miconazole and amphotericin B in Candida albicans.
    Gale EF; Johnson AM; Kerridge D; Wayman F
    J Gen Microbiol; 1980 Apr; 117(2):535-8. PubMed ID: 6999120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy.
    Bastide M; Jouvert S; Bastide JM
    Can J Microbiol; 1982 Oct; 28(10):1119-26. PubMed ID: 6295583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The porosity of the cell wall of Candida albicans.
    Cope JE
    J Gen Microbiol; 1980 Jul; 119(1):253-5. PubMed ID: 6997435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of miconazole on Candida albicans: effect on growth, viability and K+ release.
    Cope JE
    J Gen Microbiol; 1980 Jul; 119(1):245-51. PubMed ID: 6997434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post-antibiotic effect and post-exposure polyene antagonism of azole antimycotics in Candida albicans: dependency on lipophilia].
    Scheven M; Scheven Ch; Hahn K; Senf A
    Mycoses; 1995; 38 Suppl 1():14-21. PubMed ID: 7630365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of miconazole, ketoconazole and fluconazole in their effects on temperature-dependent growth and thermal death in Candida albicans.
    Madeira-Lopes A; Miranda J
    J Med Vet Mycol; 1995; 33(6):375-8. PubMed ID: 8683405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irrelevance of growth phase with respect to the Bay n 7133 and ICI 153,066 susceptibilities of Candida albicans.
    Beggs WH; Hughes CE
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):83-6. PubMed ID: 3510807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Gudewicz TM; Mader JT; Davis CP
    Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity in different media of ketoconazole, miconazole and amphotericin B against Candida lusitaniae and sucrose-negative Candida tropicalis.
    Mignini F; Prenna M; Oliveri S; Cammarata E; Falcioni E; Dainelli B; Ripa S
    Chemioterapia; 1988 Feb; 7(1):38-41. PubMed ID: 3378274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
    Ponce E; Pechère JC
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.